HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic importance of change in QRS duration over time associated with left ventricular dysfunction in patients with congestive heart failure: the DIAMOND study.

AbstractBACKGROUND:
The prognostic importance reported for QRS duration in patients with heart failure (HF) and left ventricular dysfunction varies. No prior study has investigated the prognostic importance of change in QRS duration over time.
METHODS AND RESULTS:
The Danish Investigations and Arrhythmia ON Dofetilide (DIAMOND) study randomized 1518 patients with HF to dofetilide (class III antiarrhythmic drug) or placebo. All patients had left ventricular dysfunction. QRS duration was systematically measured at randomization and every 3 months after that. During 10 years of follow-up, 1324 (89%) of the patients died. QRS duration increased from baseline by 1.36 ms (95% confidence interval [CI]: -0.26 to -2.98; P = .1) after 12 months and by 3.65 ms (CI: 0.22-7.07; P = .04) after 24 months. QRS duration measured at baseline was not of prognostic significance after multivariable adjustment (adjusted hazard ratio [HR] 1.01, CI: 0.99-1.04; P = .2 per 10-ms increment in QRS duration). The adjusted relative risk associated with a 10-ms increase in QRS duration over time was 2% (HR 1.02, CI: 1.01-1.04; P = .03). A 10-ms increment in QRS 12 months after randomization was associated with a HR of 1.05 (CI: 1.00-1.09; P = .03).
CONCLUSIONS:
In patients with left ventricular dysfunction and HF, QRS duration increased over time and the increase was associated with increasing mortality.
AuthorsEmil Loldrup Fosbøl, Marie Seibaek, Bente Brendorp, Christian Torp-Pedersen, Lars Køber, Danish Investigations and Arrhythmia on Dofetilide (Diamond) Study Group
JournalJournal of cardiac failure (J Card Fail) Vol. 14 Issue 10 Pg. 850-5 (Dec 2008) ISSN: 1532-8414 [Electronic] United States
PMID19041049 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Aged, 80 and over
  • Denmark (epidemiology)
  • Double-Blind Method
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Heart Failure (diagnosis, mortality, physiopathology)
  • Heart Rate (physiology)
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Survival Rate (trends)
  • Time Factors
  • Ventricular Dysfunction, Left (diagnosis, mortality, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: